X

Xenon Pharmaceuticals
D

XENE

60.910
USD
0.71
(1.19%)
قبل الجلسة·60.200USD-0.710(-1.17%)
حجم التداول
6,855
الربح لكل سهم
-4
العائد الربحي
-
P/E
-13
حجم السوق
5,871,435,392
أصول ذات صلة المقالات
المزيد

العنوان: Xenon Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.